Table of Contents

Editorials

• You have access

  Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer

  Lei-Jie Dai, Yu-Wei Li, Ding Ma, Zhi-Ming Shao and Yi-Zhou Jiang

  Cancer Biology & Medicine October 2023, 20 (10) 689-694; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0286
• You have access

  Immunotherapy for multiple myeloma: new chances and hope

  Jingyu Xu, Gang An and Lugui Qiu

  Cancer Biology & Medicine October 2023, 20 (10) 695-700; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0258
• You have access

  Recent advances in the systemic treatment of gastrointestinal stromal tumors

  Robin L. Jones and Marin Golčić

  Cancer Biology & Medicine October 2023, 20 (10) 701-705; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0302
• You have access

  Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer

  Qi Zhang, Jian Li, Lin Shen, Yongsheng Li and Xicheng Wang

  Cancer Biology & Medicine October 2023, 20 (10) 706-712; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0240
• You have access

  Cohort profile: design and methods of the Chinese colorectal, breast, lung, liver, and stomach cancer screening trial (C-BLAST)

  Yubei Huang, Zhangyan Lyu, Yu Zhang, Xiaomin Liu, Yacong Zhang, Ya Liu, Chao Sheng, Hongyuan Duan, Zeyu Fan, Chenyang Li, Xiao Lin, Zhuowei Feng, Lu Zheng, Zhaoxiang Ye, Hong Lu, Ying Zhu, Dejun Zhou, Xi Wei, Li Ren, Bin Meng, Fangfang Song, Fengju Song, Kexin Chen and the C-BLAST Group

  Cancer Biology & Medicine October 2023, 20 (10) 713-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0278